Schonfeld Strategic Advisors LLC Frazier Lifesciences Acquisition Corp Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.62 - $9.97 $101,141 - $1.63 Million	163,131 Added 516.99%	194,685 $1.94 Million
Q2 2022 Aug 15, 2022	BUY	$9.83 - $9.9 $24,830 - $25,007	2,526 Added 8.7%	31,554 $311,000
Q1 2022 May 16, 2022	SELL	$9.75 - $9.85 $29 - $29	-3 Reduced 0.01%	29,028 $286,000
Q3 2021 Nov 16, 2021	BUY	$9.66 - $10.0 $93,219 - $96,500	9,650 Added 49.79%	29,031 $284,000
Q2 2021 Aug 16, 2021	BUY	$9.7 - $10.14 $86,873 - $90,813	8,956 Added 85.91%	19,381 $189,000
Q1 2021 May 17, 2021	BUY	$9.67 - $10.71 $100,809 - $111,651	10,425 New	10,425 $104,000

Ticker FLAC
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 14,301,000
Description
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.